Latest autoimmune diseases Stories
MUMBAI,India, July 3, 2014 /PRNewswire/ -- - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of
- Dermira obtains exclusive rights to develop Cimzia® in psoriasis in the US, Canada and the European Union BRUSSELS and REDWOOD CITY, Calif., July 3, 2014 /PRNewswire/ -- UCB, a global biopharmaceutical
VIENNA, July 3, 2014 /PRNewswire/ -- Debilitating daily symptoms of Inflammatory Bowel Disease (IBD) not only cause depression and psychological complications in young
Brought to her knees and nearly her death by ulcerative colitis, 25 year old Karin Miller was given a second chance at life thanks to a life-saving surgery.
DailyGossip.org publishes a useful review to the Natural Multiple Sclerosis Cure program to help patients find a way to feel better and eliminate symptoms Denver,
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
NPF Psoriatic Arthritis Project to improve diagnosis, care and treatment for millions PORTLAND, Ore., June 26, 2014 /PRNewswire-USNewswire/ -- Millions of Americans with psoriatic arthritis--a
Over 300 participants walked a course of two miles led by author Andrew Louis Botieri to help raise funds that will go towards providing essential support resources and educational forums for
CHICAGO, June 25, 2014 /PRNewswire-USNewswire/ -- Bruce Richardson, M.D., Ph.D., of the University of Michigan, was honored Wednesday as the second recipient of the Lupus Insight Prize,
MENLO PARK, Calif., June 25, 2014 /PRNewswire/ -- Virobay, Inc., a clinical stage pharmaceutical company with a broad platform of cathepsin protease inhibitors being developed for the treatment
- A hairdresser.